Why Goldman Sachs Downgraded Apple Stock to Sell

Photo of Chris Lange
By Chris Lange Published
Why Goldman Sachs Downgraded Apple Stock to Sell

© Thinkstock

Apple Inc. (NASDAQ: AAPL | AAPL Price Prediction) has been one of the strongest forces in the market over the past decade. Now that the bull market is over and the COVID-19 pandemic is in full swing, analysts are adjusting. Unfortunately, one of the biggest analysts has come out against Apple in a recent report.

Goldman Sachs downgraded Apple to sell on Friday and cut its price target to $233 from $250, as it reduced its earnings estimates for a third time since February 17.

[in-text-ad]

Analysts, led by Rod Hall, said they are modeling a far deeper reduction in unit demand through mid-2020 followed by a shallower recovery heading into 2021. The investment house detailed in its report:

We also assume some lingering ASP (average selling price) weakness as consumers look to economize similar to what we have seen in prior downturns. In addition to this we believe that Services growth slows substantially in 2021 and that Services as a percentage of revenue actually stagnates in that year.

[nativounit]

Overall, Goldman Sachs is expecting a 36% decline in iPhone unit demand in the second quarter and a 24% decline in the first half of calendar 2020. Analysts anticipate the company’s other products will experience a similar trajectory.

Goldman Sachs further detailed:

There are multiple examples of ASPs dropping in the midst of a recession and then remaining weak well beyond the point when units recover. Price weakness could affect 5G design choices too, and limited global travel may cause the delay of the launch of this year’s updated iPhone.

Apple stock traded down more than 2% at $280.32 on Friday, in a 52-week range of $170.27 to $327.85. The consensus price target is $304.56.

[recirclink id=682812][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

SMCI Vol: 128,836,317
ON Vol: 12,044,310
GLW Vol: 18,574,393
MU Vol: 53,140,821
ABBV Vol: 9,912,803

Top Losing Stocks

CTRA Vol: 73,319,495
MRNA Vol: 8,363,487
PLTR Vol: 56,918,231
VRSN Vol: 1,691,263
CMG Vol: 18,457,730